Information  X 
Enter a valid email address

Allergy Therapeutics (AGY)

  Print      Mail a friend

Friday 30 March, 2012

Allergy Therapeutics

Grant of Options

RNS Number : 4166A
Allergy Therapeutics PLC
30 March 2012
 



30 March 2012

 

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

 

Grant of Options

 

Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP'), on 30 March 2012 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:

 

Director

Number of provisional shares awarded

Date of distribution

Total provisional shares held under LTIPs

Manuel Llobet

720,000

30 March 2012

 2,190,000

Ian Postlethwaite

360,000

30 March 2012

 1,320,000

 

The distribution of these ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of the next three years.

 

 

-Ends-

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 845 820

Manuel Llobet, Chief Executive Officer




Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw




 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGGDXGBXBGDG